Traders should monitor for additional developments in the lawsuit, including potential settlement or further adverse disclosures. The August 4, 2026 lead plaintiff deadline may attract additional investor attention and legal filings, but the primary stock-moving event (the trial failure and stock drop) has already occurred. No immediate catalyst for further price movement is present from this filing alone.
Price Chart
Executive Summary
Berger Montague has announced a securities fraud class action lawsuit against GRAIL, Inc. (GRAL) on behalf of investors who purchased stock between May 13, 2025 and February 19, 2026. The lawsuit alleges that GRAIL failed to disclose that its NHS-Galleri trial was insufficient to demonstrate its primary endpoint, and that on February 19, 2026, the company disclosed the trial's primary endpoint was not met, causing the stock to drop ~50.55% in a single day. This is a litigation announcement, not a corporate event, and the deadline for lead plaintiff appointment is August 4, 2026.
Key Facts
- Class action lawsuit filed against GRAIL for alleged securities fraud during the period May 13, 2025 through February 19, 2026.
- The complaint alleges GRAIL failed to disclose that the NHS-Galleri trial was insufficient to demonstrate a statistically significant reduction in Stage III-IV cancers.
- On February 19, 2026, GRAIL disclosed the trial's primary endpoint was not met, causing shares to fall from $101.53 to $50.21, a decline of approximately 50.55% in a single trading day.
- Lead plaintiff deadline is August 4, 2026.
Financial Impact
Stock declined approximately 50.55% on the day of the disclosure (February 19, 2026), from $101.53 to $50.21 per share.
Risk Factors
- Potential for additional negative disclosures or trial data updates.
- Risk of further litigation costs or settlement payments.
- Uncertainty around the NHS-Galleri trial's longer follow-up period and any future data readouts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302836294 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Insider Cluster | $79.79 $140.12 | ▲ +75.61% | ▲ +75.29% | $132.56 (+66.14%) |
Jul 28, 2026 9w ago | Press Release | $64.42 $82.54 | ▼ −28.13% | ▼ −24.75% | $132.56 (−105.77%) |
Jun 11, 2026 16w ago | Institutional Cluster | $60.16 $75.79 | ▲ +25.98% | ▲ +24.09% | $132.56 (+120.35%) |
Apr 28, 2026 22w ago | DEFA14A | $49.69 $73.92 | ▲ +48.76% | ▲ +42.71% | $132.56 (+166.77%) |
Apr 8, 2026 25w ago | Insider Cluster | $50.78 $54.40 | ▼ −7.13% | ▲ +1.42% | $132.56 (−161.05%) |
Mar 2, 2026 30w ago | Insider Cluster | $52.63 $46.90 | ▲ +10.89% | ▲ +2.95% | $132.56 (−151.87%) |
Mar 2, 2026 30w ago | Insider Cluster | $52.63 $46.90 | ▲ +10.89% | ▲ +2.95% | $132.56 (−151.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access